S
Seyed Ebrahim Alavi
Researcher at University of Queensland
Publications - 47
Citations - 769
Seyed Ebrahim Alavi is an academic researcher from University of Queensland. The author has contributed to research in topics: Drug delivery & Medicine. The author has an hindex of 14, co-authored 36 publications receiving 399 citations. Previous affiliations of Seyed Ebrahim Alavi include Pasteur Institute of Iran & Rafsanjan University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer's disease.
Sitah Al Harthi,Sitah Al Harthi,Sitah Al Harthi,Seyed Ebrahim Alavi,Mahasen Ali Radwan,Mona Mohamed El Khatib,Mona Mohamed El Khatib,Ibrahim A. Alsarra +7 more
TL;DR: The results suggested that liposomes dispersed into TCH is a promising device for the nasal delivery of DH and can be considered for the treatment of Alzheimer’s disease.
Journal ArticleDOI
Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances.
Mohsen Ghaferi,Maedeh Koohi Moftakhari Esfahani,Aun Raza,Sitah Al Harthi,Sitah Al Harthi,Hasan Ebrahimi Shahmabadi,Seyed Ebrahim Alavi +6 more
TL;DR: A literature review will take an in-depth look into the properties of various types of Mesoporous silica nanoparticles, and discuss their characteristics, in terms of cellular uptake, drug delivery and release, and their therapeutic applications, biocompatibility and safety issues.
Journal ArticleDOI
Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma
Hasan Ebrahimi Shahmabadi,Fatemeh Movahedi,Maedeh Koohi Moftakhari Esfahani,Seyed Ebrahim Alavi,Ali Eslamifar,Gholamreza Mohammadi Anaraki,Azim Akbarzadeh +6 more
TL;DR: Prepared PBCA NPs presented acceptable stability after 2 months and lyophilization and can be considered as a promising nanocarrier for other types of tumor.
Journal ArticleDOI
Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation.
Mohsen Ghaferi,Mohammad Javad Asadollahzadeh,Azim Akbarzadeh,Hasan Ebrahimi Shahmabadi,Seyed Ebrahim Alavi,Seyed Ebrahim Alavi +5 more
TL;DR: The PEGylation of LCispt is a promising approach to achieve a nanoformulation with enhanced anticancer effects and reduced toxicity compared to Cispt for the treatment of BC.
Journal ArticleDOI
Preparation, Characterization, and Evaluation of Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved In Vitro and In Vivo Anticancer Activities.
Mohsen Ghaferi,Mohsen Ghaferi,Samar Amari,Bhalchandra Vivek Mohrir,Aun Raza,Hasan Ebrahimi Shahmabadi,Seyed Ebrahim Alavi,Seyed Ebrahim Alavi +7 more
TL;DR: Cisplatin-loaded PBCA nanoparticles can be considered as a promising drug candidate for the treatment of kidney cancer due to its potency to reduce the side effects of cisplatin and its toxicity and therapeutic effects on cancer-bearing Wistar rats.